403 related articles for article (PubMed ID: 34372691)
1. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.
Zhu Z; Antenucci F; Villumsen KR; Bojesen AM
mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691
[TBL] [Abstract][Full Text] [Related]
2. Outer Membrane Vesicles Protect Gram-Negative Bacteria against Host Defense Peptides.
Balhuizen MD; van Dijk A; Jansen JWA; van de Lest CHA; Veldhuizen EJA; Haagsman HP
mSphere; 2021 Aug; 6(4):e0052321. PubMed ID: 34232080
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
4. Rapid prototyping vaccine approach in mice against multi-drug resistant Gram-negative organisms from clinical isolates based on outer membrane vesicles.
Pritsch M; Ben Khaled N; Liegl G; Schubert S; Hoelscher M; Woischke C; Arens N; Thorn-Seshold J; Kammermeier S; Wieser A
Microbiol Immunol; 2021 May; 65(5):214-227. PubMed ID: 33650163
[TBL] [Abstract][Full Text] [Related]
5. Gram-negative outer membrane vesicles in vaccine development.
Collins BS
Discov Med; 2011 Jul; 12(62):7-15. PubMed ID: 21794204
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with outer membrane vesicles and the fimbrial protein FlfA offers improved protection against lesions following challenge with Gallibacterium anatis.
Persson G; Pors SE; Thøfner ICN; Bojesen AM
Vet Microbiol; 2018 Apr; 217():104-111. PubMed ID: 29615242
[TBL] [Abstract][Full Text] [Related]
7. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
[TBL] [Abstract][Full Text] [Related]
8. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
Huang W; Meng L; Chen Y; Dong Z; Peng Q
Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
[TBL] [Abstract][Full Text] [Related]
9. Proteome-minimized outer membrane vesicles from
Zanella I; König E; Tomasi M; Gagliardi A; Frattini L; Fantappiè L; Irene C; Zerbini F; Caproni E; Isaac SJ; Grigolato M; Corbellari R; Valensin S; Ferlenghi I; Giusti F; Bini L; Ashhab Y; Grandi A; Grandi G
J Extracell Vesicles; 2021 Feb; 10(4):e12066. PubMed ID: 33643549
[TBL] [Abstract][Full Text] [Related]
10. OMV Vaccines and the Role of TLR Agonists in Immune Response.
Mancini F; Rossi O; Necchi F; Micoli F
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921
[TBL] [Abstract][Full Text] [Related]
11. [Advances in outer membrane vesicles of gram-negative bacteria as sub-unit vaccines - A review].
Yi J; Liu Q; Kong Q
Wei Sheng Wu Xue Bao; 2016 Jun; 56(6):911-21. PubMed ID: 29727152
[TBL] [Abstract][Full Text] [Related]
12. Outer membrane vesicles of Gallibacterium anatis induce protective immunity in egg-laying hens.
Pors SE; Pedersen IJ; Skjerning RB; Thøfner ICN; Persson G; Bojesen AM
Vet Microbiol; 2016 Nov; 195():123-127. PubMed ID: 27771057
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
Lei EK; Azmat A; Henry KA; Hussack G
Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
[TBL] [Abstract][Full Text] [Related]
14. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
[TBL] [Abstract][Full Text] [Related]
15. Bacterial outer membrane vesicles as a platform for biomedical applications: An update.
Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y
J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919
[TBL] [Abstract][Full Text] [Related]
16. Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application.
Furuyama N; Sircili MP
Biomed Res Int; 2021; 2021():1490732. PubMed ID: 33834062
[TBL] [Abstract][Full Text] [Related]
17. Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine Development.
Valguarnera E; Feldman MF
Methods Enzymol; 2017; 597():285-310. PubMed ID: 28935107
[TBL] [Abstract][Full Text] [Related]
18. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
[No Abstract] [Full Text] [Related]
19. Bacterial outer membrane vesicles as a candidate tumor vaccine platform.
Wang S; Guo J; Bai Y; Sun C; Wu Y; Liu Z; Liu X; Wang Y; Wang Z; Zhang Y; Hao H
Front Immunol; 2022; 13():987419. PubMed ID: 36159867
[TBL] [Abstract][Full Text] [Related]
20. Characterization and Vaccine Potential of Outer Membrane Vesicles Produced by Haemophilus parasuis.
McCaig WD; Loving CL; Hughes HR; Brockmeier SL
PLoS One; 2016; 11(3):e0149132. PubMed ID: 26930282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
